← Eichor
Study identifier: NCT07045623 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Comparison of Intensive Versus Standard Care & Education for Dyslipidemia in Hypertension and Diabetes Patients

Condition: Hypertension · Diabetes Mellitus · Dyslipidemia  ·  Sponsor: Saint Vincent's Hospital, Korea

PhaseNA
Planned participants348
Who can joinAll sexes, 30 Years to 80 Years
Healthy volunteersNo

About this study

The prevalence of dyslipidemia is high among patients with hypertension and diabetes mellitus, which increases the risk of cardiovascular disease. However, many patients lack awareness and adherence to treatment and lifestyle modifications. Therefore, a more structured and intensive approach to management and education is required. This study aims to implement intensive dyslipidemia management and education for patients registered at the Hanam City Hypertension and Diabetes Education Center and evaluate changes in blood lipid levels accordingly. Additionally, the study will analyze the impact of intensive education on patients' quality of life, health behaviors, and treatment adherence, ultimately contributing to the development of effective management strategies.

This description comes directly from the study's public registry record.

Talk to the study team

Sung-Ho Her  ·  +82312598397  ·  hhhsungho@naver.com

Always discuss trial participation with your own doctor first.

Locations (1)

Catholic University of Korea, ST. Vincent's Hospital.Gyeonggi-do, Suwon-si, South KoreaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07045623